CClinicalTrials.gg
CompletedNCT00051246Updated Jan 24, 2014

Group Therapy for Postpartum Depression

An interventional study of Mother-Infant Group Psychotherapy and Interpersonal Psychotherapy in Depression, Postpartum, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-01-24.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
147
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This study will compare standard individual treatment to group therapy for the treatment of postpartum depression.

Read the detailed description

Ten to twenty percent of new mothers experience major depression in the postpartum period or postpartum depression (PPD). This condition poses a risk for disturbances in the mother-infant relationship as well as for developmental delays and subsequent psychopathology in their children. Thus, and investigation of the efficacy of a relational approach that focuses on improving the mother's sense of competence in the parenting role, and reducing depressive symptoms and social isolation through group therapy is warranted.

Patients are randomly assigned to either relational group treatment or to standard individual treatment. Assessments of maternal and infant functioning, mother-infant and father-infant relations, parenting stress, and marital conflict and conducted pre- and post-treatment, at 12 months post-treatment, and when infants are 12 and 24 months of age.

02

Conditions studied

03

In context

Depression, Postpartum

528 studies on the registry are indexed under Depression, Postpartum; 124 are open to participants now.

This study's enrollment of 147 is above the median of 105 across 425 interventional studies indexed under Depression, Postpartum.

Browse Depression, Postpartum studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Major depression with an infant under 7 months of age

Exclusion criteria

Exclusion Criteria:

  • Bipolar disorder
  • Schizophrenia
  • Organic brain syndrome
  • Antisocial personality disorder
  • Current psychosis or mania
  • Lifetime history of mental retardation
  • Current alcohol or substance abuse
  • Cognitive disability
  • Infants born more than 6 weeks premature or with major medical conditions or developmental disabilities
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
147 participants (actual)

Study arms

  • Active comparator
    1 M-ITG

    Mother-infant group psychotherapy

    Behavioral: Mother-Infant Group Psychotherapy

  • Active comparator
    2 - IPT

    Individual interpersonal psychotherapy

    Behavioral: Interpersonal Psychotherapy

Interventions

  • BehavioralMother-Infant Group Psychotherapy

    Mother-infant group psychotherapy consists of weekly 2.5-hour psychotherapy sessions comprised of mother's group therapy, infant developmental therapy, and mother-infant dyadic psychotherapy. Group treatment will last 15 weeks.

  • BehavioralInterpersonal Psychotherapy

    Individual psychotherapy treatment focuses on role transition, interpersonal relationships, and loss. Individual treatment period will last 15 weeks.

06

What researchers measure

Primary outcomes

  1. Reduction of depression as measured by the Hamilton Rating Scale for Depression (HRSD)

    Time frame: Measured at post-treatment and Month 12 follow-up

Secondary outcomes

  1. Improvement in parent-infant interactions as measured by the Early Relational Assessment (ERA)

    Time frame: Measured at post-treatment, Month 12 follow-up, and 12 and 24 months of age

07

Study locations

1 site
  • University of Wisconsin Dept. of Psychiatry
    Madison, Wisconsin 53719, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00051246
Lead sponsor
University of Wisconsin, Madison
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Jan 8, 2003
Start date
Jan 2002
Primary completion
Jul 2008
Completion
Jul 2008
Last update
Jan 24, 2014

Study contacts

Roseanne Clark, PhD
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion